BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/26/2016 7:12:00 PM | Browse: 1327 | Download: 2593
 |
Received |
|
2016-04-14 09:41 |
 |
Peer-Review Started |
|
2016-04-14 11:51 |
 |
To Make the First Decision |
|
2016-06-20 09:03 |
 |
Return for Revision |
|
2016-06-20 15:19 |
 |
Revised |
|
|
 |
Second Decision |
|
2016-07-21 10:14 |
 |
Accepted by Journal Editor-in-Chief |
|
2016-07-21 16:11 |
 |
Accepted by Executive Editor-in-Chief |
|
2016-08-01 14:13 |
 |
Articles in Press |
|
2016-08-01 14:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2016-12-19 11:53 |
 |
Publish the Manuscript Online |
|
2016-12-26 19:13 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Clinical Trials Study |
Article Title |
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Anna Lyra, Markku Hillilä, Teppo Huttunen, Sofia Männikkö, Mikko Taalikka, Julia Tennilä, Anneli Tarpila, Sampo Lahtinen, Arthur C Ouwehand and Lea Veijola |
Funding Agency and Grant Number |
|
Corresponding Author |
Anna Lyra, PhD, Senior Scientist, DuPont Nutrition and Health, Global Health and Nutrition Science, Danisco Sweeteners Oy, Sokeritehtaantie 20, 02460 Kantvik, Finland. anna.lyra@dupont.com |
Key Words |
Irritable bowel syndrome; Functional bowel disorder; Symptom questionnaire; Quality of life; Visceral pain; Abdominal pain; Lactobacillus acidophilus; Probiotic; Intervention |
Core Tip |
Symptoms of irritable bowel syndrome (IBS) might benefit from probiotic interventions, although mechanistic insights into probiotic function are seldom available. Lactobacillus acidophilus NCFM induces human colonic mucosal opioid receptor expression - the putative mechanism by which visceral pain is alleviated. In this study, 391 volunteers with IBS were treated with 109 or 1010 colony-forming units of NCFM or placebo and evaluated using symptom questionnaires. NCFM was not superior to placebo in improving the composite IBS symptom score, whereas abdominal pain - as an individual symptom - declined in IBS volunteers with moderate to severe pain at baseline. |
Publish Date |
2016-12-26 19:13 |
Citation |
Lyra A, Hillilä M, Huttunen T, Männikkö S, Taalikka M, Tennilä J, Tarpila A, Lahtinen S, Ouwehand AC, Veijola L. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo. World J Gastroenterol 2016; 22(48): 10631-10642 |
URL |
http://www.wjgnet.com/1007-9327/full/v22/i48/10631.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v22.i48.10631 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345